Lympadenectomy in Prostate Cancer

dc.contributor.authorKosan, Murat
dc.date.accessioned2024-03-18T12:04:49Z
dc.date.available2024-03-18T12:04:49Z
dc.date.issued2014
dc.description.abstractAim: Radical prostatectomy is the standard treatment in localized prostate cancer. The limited or extended lymph node dissection in pelvic region is additionally applied to this procedure. We aimed to review the publications about the recently popularized extended pelvic lymph node dissection (PLND). New Findings: The extended PLND is not suggested in patients with low risk prostate cancer. On the other hand, extended PLND is suggested to make a good staging and treat the micrometastasis in patients with intermediate and high risk prostate cancer. The complication rates of PLND are acceptable in comparison with the benefits. The benefits of other expansive methods for clinical staging are still lower than PLND. Conclusion: However, prospective and randomized clinical trials are needed to investigate the efficiency of PLND in localized prostate cancer, PLND has important role with good oncological results in patients with intermediate and high risk prostate cancer.en_US
dc.identifier.endpage28en_US
dc.identifier.issn2147-2270en_US
dc.identifier.issue1en_US
dc.identifier.startpage25en_US
dc.identifier.urihttp://hdl.handle.net/11727/11855
dc.identifier.volume13en_US
dc.identifier.wos000219409700006en_US
dc.language.isoturen_US
dc.relation.journalUROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGYen_US
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi en_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectPelvic lymph node dissectionen_US
dc.subjectProstate canceren_US
dc.subjectRadical prostatectomyen_US
dc.titleLympadenectomy in Prostate Canceren_US
dc.typearticleen_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: